Johnson & Johnson vaccine authorized by Northwest multi-state review group

Johnson & Johnson
Johnson & Johnson/AP
This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the COVID-19 vaccine in the United States. The Centers for Disease Control and Prevention vaccine advisers voted Sunday to recommend the Johnson & Johnson Covid-19 vaccine for the US. It is the first of the three authorized Covid-19 vaccines that comes in a single dose.

OLYMPIA, Wash. (AP) — The Johnson & Johnson COVID-19 vaccine has been authorized by the Western States Scientific Safety Review Workgroup, Washington Gov. Jay Inslee announced Wednesday.

The group — comprised of public health experts from Washington, California, Oregon and Nevada — was created last year to independently review the safety and efficacy of any coronavirus vaccine approved by the FDA before any distribution occurs in those states.

Their decision on the latest vaccine comes after the FDA and CDC granted their initial authorization for the vaccine. The group had previously reviewed the Pfizer and Moderna vaccines before the state started its vaccination process in December.

RELATED: Biden vows enough vaccine for all US adults by end of May

An estimated 60,000 doses of the vaccine are expected to arrive in the state this week.

“The Workgroup’s authorization gives us further confidence around the safety and efficacy of the J & J vaccine,” Inslee said. “Like the other two, this vaccine offers strong protection against serious illness from COVID-19, which is critical in our fight against this deadly virus.”

More than 1.6 million doses of the two-shot Pfizer and Moderna vaccines have been administered to date, and nearly 8% of the state’s population has been fully vaccinated. The J& J vaccine only requires one shot.

COVID-19 Vaccine Headlines: 

RELATED: South African COVID-19 variant detected in Washington

RELATED: Washington educators are now eligible to be vaccinated